ARTICLE | Company News
Sunol, Novo Nordisk deal
November 22, 1999 8:00 AM UTC
Novo Nordisk received an exclusive worldwide license to Sunol's small molecule Tissue Factor antagonists and additional exclusive worldwide rights to Tissue Factor antagonist leads identified through...